Did You Know?

Editor’s Picks

Latest News

Nurix Therapeutics Doses First Patient in Phase 1 Clinical Trial of DeTIL-0255, a Drug-Enhanced Cell Therapy for the Treatment of Patients with Solid Tumors

First in human study of drug-enhanced tumor infiltrating lymphocyte therapy in patients with gynecological malignanciesSAN FRANCISCO, April 05, 2022 (GLOBE...

Tinley’s Confirms First Non-Alcoholic Beer Production at Long Beach Facility; Tinley’s Brand Products Launch in Ontario, Canada; Other Corporate Updates

Toronto, Ontario and Los Angeles, California--(Newsfile Corp. - April 5, 2022) - The Tinley Beverage Company Inc. (CSE:TNY) (OTCQX: TNYBF)...

Kyruus Welcomes Gail Airasian as General Manager of Emerging Markets as the Company Expands Its Platform to Serve the Broader Digital Health Market

Seasoned Healthcare Industry Executive Joins Organization to Lead Business Development, Acquisitions, and Expansion into New Markets BOSTON--(BUSINESS WIRE)--Kyruus, the leader...

error: Content is protected !!